Literature DB >> 4126917

A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.

W D Revill, R H Morrow, M C Pike, J Ateng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4126917     DOI： 10.1016/s0140-6736(73)92005-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  35 in total

1.  Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer.

Authors:  Dorothy Yeboah-Manu; Adwoa Asante-Poku; Kobina Asan-Ampah; Emelia Danso Edwin Ampadu; Gerd Pluschke
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 2.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

3.  Buruli ulcer.

Authors:  Mark Wansbrough-Jones; Richard Phillips
Journal:  BMJ       Date:  2005-06-18

4.  Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Authors:  S Etuaful; B Carbonnelle; J Grosset; S Lucas; C Horsfield; R Phillips; M Evans; D Ofori-Adjei; E Klustse; J Owusu-Boateng; G K Amedofu; P Awuah; E Ampadu; G Amofah; K Asiedu; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer.

Authors:  Claire L Gordon; John A Buntine; John A Hayman; Caroline J Lavender; Janet A Fyfe; Patrick Hosking; Paul D R Johnson
Journal:  PLoS Negl Trop Dis       Date:  2011-10-25

6.  Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans.

Authors:  Diana Diaz; Heinz Döbeli; Dorothy Yeboah-Manu; Ernestina Mensah-Quainoo; Arno Friedlein; Nicole Soder; Simona Rondini; Thomas Bodmer; Gerd Pluschke
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

7.  Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.

Authors:  Fred Stephen Sarfo; Richard Phillips; Kingsley Asiedu; Edwin Ampadu; Nana Bobi; E Adentwe; Awuli Lartey; Ishmael Tetteh; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

8.  Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Authors:  A Bentoucha; J Robert; H Dega; N Lounis; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.

Authors:  R Phillips; O Adjei; S Lucas; N Benjamin; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer.

Authors:  R O Phillips; F S Sarfo; F Osei-Sarpong; A Boateng; I Tetteh; A Lartey; E Adentwe; W Opare; K B Asiedu; M Wansbrough-Jones
Journal:  J Clin Microbiol       Date:  2009-02-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.